These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38462668)
1. Predictive role of the prognostic nutritional index in patients with pancreatic ductal adenocarcinoma who underwent neoadjuvant chemoradiotherapy followed by curative pancreatic resection: A retrospective study using prospectively collected data. Suto H; Matsukawa H; Ando Y; Oshima M; Fuke T; Nagao M; Yamana H; Kamada H; Kumamoto K; Okano K J Hepatobiliary Pancreat Sci; 2024 Mar; ():. PubMed ID: 38462668 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma. Suto H; Oshima M; Ando Y; Matsukawa H; Takahashi S; Shibata T; Kamada H; Kobara H; Masaki T; Kumamoto K; Suzuki Y; Okano K HPB (Oxford); 2023 Jan; 25(1):136-145. PubMed ID: 36307256 [TBL] [Abstract][Full Text] [Related]
3. Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study. Suto H; Fuke T; Matsukawa H; Ando Y; Oshima M; Nagao M; Takahashi S; Shibata T; Yamana H; Kamada H; Kobara H; Okuyama H; Kumamoto K; Okano K J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592055 [No Abstract] [Full Text] [Related]
4. Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection. Kubo H; Murakami T; Matsuyama R; Yabushita Y; Tsuchiya N; Sawada Y; Homma Y; Kumamoto T; Endo I World J Surg; 2019 Dec; 43(12):3153-3160. PubMed ID: 31549202 [TBL] [Abstract][Full Text] [Related]
5. Relationships between postoperative recurrences and standardized uptake value on Suto H; Nagao M; Matsukawa H; Fuke T; Ando Y; Oshima M; Takahashi S; Shibata T; Kamada H; Kobara H; Okuyama H; Hirao T; Kumamoto K; Okano K Pancreatology; 2024 Nov; 24(7):1133-1140. PubMed ID: 39160121 [TBL] [Abstract][Full Text] [Related]
6. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488 [TBL] [Abstract][Full Text] [Related]
7. Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting. Fujii T; Satoi S; Yamada S; Murotani K; Yanagimoto H; Takami H; Yamamoto T; Kanda M; Yamaki S; Hirooka S; Kon M; Kodera Y J Gastroenterol; 2017 Jan; 52(1):81-93. PubMed ID: 27169844 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study. Itoh S; Tsujita E; Fukuzawa K; Sugimachi K; Iguchi T; Ninomiya M; Maeda T; Kajiyama K; Adachi E; Uchiyama H; Utsunomiya T; Ikeda Y; Maekawa S; Toshima T; Harada N; Yoshizumi T; Mori M Pancreatology; 2021 Oct; 21(7):1356-1363. PubMed ID: 34426076 [TBL] [Abstract][Full Text] [Related]
9. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study. Suto H; Matsukawa H; Fuke T; Nagao M; Ando Y; Oshima M; Yamana H; Kamada H; Kobara H; Okuyama H; Kumamoto K; Okano K Pancreatology; 2024 May; 24(3):431-436. PubMed ID: 38383175 [TBL] [Abstract][Full Text] [Related]
10. Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy. Suto H; Okano K; Oshima M; Ando Y; Matsukawa H; Takahashi S; Shibata T; Kamada H; Masaki T; Suzuki Y J Surg Oncol; 2022 Aug; 126(2):292-301. PubMed ID: 35289928 [TBL] [Abstract][Full Text] [Related]
11. Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer. Oshima M; Okano K; Suto H; Ando Y; Kamada H; Masaki T; Takahashi S; Shibata T; Suzuki Y BMC Gastroenterol; 2020 Dec; 20(1):423. PubMed ID: 33317455 [TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection without preoperative neoadjuvant treatment: A systematic review and meta-analysis. Zhao P; Wu Z; Wang Z; Wu C; Huang X; Tian B Front Surg; 2022; 9():992641. PubMed ID: 36157419 [TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With Pancreatic Cancer Treated With Perioperative Adjuvant Chemotherapy. Kawahara S; Aoyama T; Murakawa M; Kanemoto R; Takahashi D; Kamioka Y; Hashimoto I; Maezawa Y; Kobayashi S; Ueno M; Yamamoto N; Oshima T; Yukawa N; Rino Y; Saito A; Morinaga S Anticancer Res; 2024 Apr; 44(4):1711-1718. PubMed ID: 38537971 [TBL] [Abstract][Full Text] [Related]
14. Clinical importance of preoperative and postoperative prognostic nutritional index in patients with pancreatic ductal adenocarcinoma. Ikeguchi M; Goto K; Watanabe J; Urushibara S; Osaki T; Endo K; Tatebe S; Nakamura S Ann Hepatobiliary Pancreat Surg; 2019 Nov; 23(4):372-376. PubMed ID: 31825004 [TBL] [Abstract][Full Text] [Related]
15. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection. Kim NH; Kim HJ Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection. Tsuchiya N; Matsuyama R; Murakami T; Yabushita Y; Sawada YU; Kumamoto T; Endo I Anticancer Res; 2019 Aug; 39(8):4431-4440. PubMed ID: 31366541 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer. Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783 [TBL] [Abstract][Full Text] [Related]
18. Oncologic impact of preoperative prognostic nutritional index change in resected pancreatic cancer following neoadjuvant chemotherapy. Kim KH; Hwang HK; Kang IC; Lee WJ; Kang CM Pancreatology; 2020 Mar; 20(2):247-253. PubMed ID: 31889624 [TBL] [Abstract][Full Text] [Related]
19. Effect of the preoperative prognostic nutritional index on the long-term prognosis in patients with borderline resectable pancreatic cancer after pancreaticoduodenectomy. Huang JC; Pan B; Jiang T; Zhang XX; Lyu SC; Lang R Front Oncol; 2023; 13():1098459. PubMed ID: 37197434 [TBL] [Abstract][Full Text] [Related]
20. Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy. Takaichi S; Tomimaru Y; Kobayashi S; Toya K; Sasaki K; Iwagami Y; Yamada D; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H Ann Surg Oncol; 2023 Apr; 30(4):2458-2468. PubMed ID: 36575288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]